EUDA Health Holdings Ltd (EUDA): Nasdaq/NYSE listing notice — EUDA Health receives Nasdaq delisting notice for failure to file Q1 2023 10-Q

EUDA Health Holdings Ltd

Received delinquency notice from Nasdaq on May 18, 2023 for not filing Q1 2023 Form 10-Q.
Previously missed FY2022 10-K; must submit compliance plan by June 5, 2023.
If plan accepted, extension to September 27, 2023 to file both 10-K and 10-Q.
Failure to regain compliance could lead to delisting of EUDA common stock and warrants.
Management says substantial part of filings completed but needs more time.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

EUDA Health Holdings Ltd received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

f this date. However, the Company requires additional time to prepare, review and finalize its financial statements. The Notice has no immediate impact on the listing of the Company’s common stock, which will continue to trade on Nasdaq under the symbol “EUDA”. As required under Nasdaq Listing Rule 5250(b)(2), the Company issued a press release on May 19, 2023, announcing that it had received the Notice. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K. Forward-Looking Statements This Form 8-K contains forward-looking statements, including statements about the financia

View on SEC.gov

Browse all listing & compliance notices →

EUDA Health Holdings Ltd filing history →

Source: SEC EDGAR

accession 0001493152-23-018338

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.